Phase 1/2 study of cirmtuzumab and ibrutinib in mantle cell lymphoma (MCL) or chronic lymphocytic leukemia (CLL).

被引：16
|
作者：
Lee, Hun Ju
Choi, Michael Y.
Siddiqi, Tanya
Barrientos, Jacqueline Claudia
Wierda, William G.
Isufi, Iris
Tuscano, Joseph M.
Lamanna, Nicole
Subbiah, Suki
Koff, Jean Louise
Leslie, Lori Ann
Goldenberg, Alec
Chung, Gina G.
Breitmeyer, James Bradley
Hsu, Frank J.
Wang, Michael
Jamieson, Catriona
Kipps, Thomas J.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA
[2] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA
[3] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA
[4] Northwell Hlth, Feinstein Inst Med Res, Karches Ctr Oncol Res, Manhasset, NY USA
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[6] Yale Univ, Sch Med, Hematol, New Haven, CT USA
[7] Univ Calif Davis, Davis, CA 95616 USA
[8] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, New York, NY USA
[9] LSU Hlth Sci Ctr, New Orleans, LA USA
[10] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
[11] John Theurer Canc Ctr, Lymphoma Res Div, Hackensack, NJ USA
[12] Manhattan Hem Onc Associates, New York, NY USA
[13] Christ Hosp, Lindner Ctr Res & Educ, Cincinnati, OH 45219 USA
[14] Oncternal Therapeut Inc, San Diego, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.7556
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7556
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma-Like Mantle Cell Lymphoma
    Xu, Jie
    Wang, Sa
    Wang, Lifu
    Tang, Guilin
    Lin, Pei
    Yin, C. Cameron
    Medeiros, L. Jeffrey
    Li, Shaoying
    MODERN PATHOLOGY, 2019, 32
  • [42] Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma-Like Mantle Cell Lymphoma
    Xu, Jie
    Wang, Sa
    Wang, Lifu
    Tang, Guilin
    Lin, Pei
    Yin, C. Cameron
    Medeiros, L. Jeffrey
    Li, Shaoying
    LABORATORY INVESTIGATION, 2019, 99
  • [43] Ligands That Mimic the Tissue Microenvironment of Replicating Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL) Protect Ex Vivo Patient Cell Samples from the Cytotoxicity of Combined Treatment with Ibrutinib and Venetoclax (ABT-1 99)
    Jayappa, Kallesh D.
    Portell, Craig A.
    Gordon, Vicki
    Williams, Michael E.
    Petricoin, Emanuel F.
    Bender, Timothy P.
    Weber, Michael J.
    BLOOD, 2015, 126 (23)
  • [44] Activity and Tolerability of Ibrutinib in Combination With Ofatumumab in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
    Jaglowski, Samantha M.
    Jones, Jeffrey A.
    Flynn, Joseph M.
    Andritsos, Leslie A.
    Maddocks, Kami J.
    Woyach, Jennifer A.
    Blum, Kristie A.
    Greyer, Michael R.
    Geyer, Susan Michelle
    Heerema, Nyla A.
    Lozanski, Gerard
    Stefanos, Mona
    Hall, Nathan
    Nagar, Veena
    Munneke, Brian
    West, Jamie-Sue
    Neuenburg, Jutta K.
    James, Danelle F.
    Johnson, Amy J.
    Byrd, John C.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S206 - S207
  • [45] Pharmacokinetics (PK) of ibrutinib in patients with chronic lymphocytic leukemia (CLL)
    Sukbuntherng, Juthamas
    Jejurkar, Purvi
    Chan, Stephen
    Tran, Anh L.
    Moussa, Davina
    James, Danelle Frances
    Loury, David
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [46] FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia
    de Claro, R. Angelo
    McGinn, Karen M.
    Verdun, Nicole
    Lee, Shwu-Luan
    Chiu, Haw-Jyh
    Saber, Haleh
    Brower, Margaret E.
    Chang, C. J. George
    Pfuma, Elimika
    Habtemariam, Bahru
    Bullock, Julie
    Wang, Yun
    Nie, Lei
    Chen, Xiao-Hong
    Lu, Donghao
    Al-Hakim, Ali
    Kane, Robert C.
    Kaminskas, Edvardas
    Justice, Robert
    Farrell, Ann T.
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2015, 21 (16) : 3586 - 3590
  • [47] Phase 1b Results of a Phase 1b/2 Study of Obinutuzmab, Ibrutinib, and Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
    Jones, Jeffrey A.
    Woyach, Jennifer
    Awan, Farrukh T.
    Maddocks, Kami J.
    Whitlow, Thomas
    Ruppert, Amy S.
    Byrd, John C.
    BLOOD, 2016, 128 (22)
  • [48] Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL): A Case Study
    Nanni, Danielle
    JOURNAL OF DIAGNOSTIC MEDICAL SONOGRAPHY, 2024, 40 (03) : 289 - 293
  • [49] Phase 3 BELLWAVE-011 Study: Nemtabrutinib Versus Ibrutinib or Acalabrutinib in Previously Untreated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
    Tadmor, Tamar
    Eyre, Toby A.
    Benjamini, Ohad
    Chaudhry, Arvind
    Shen, Juan
    Leng, Siyang
    Farooqui, Mohammed
    Lavie, David
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S352 - S353
  • [50] Recurrent abnormalities associated with t(11;14) in mantle-cell lymphoma (MCL) or chronic lymphocytic leukemia (CLL): A cytogenetic and comparative genomic hybridization (CGH) study.
    Gressin, R
    Callanan, M
    Le Baccon, P
    Peoc'h, M
    Jacob, MC
    Sotto, MF
    Sotto, JJ
    Leroux, D
    BLOOD, 1998, 92 (10) : 183B - 183B
12345